Starpharma Holdings Limited (ASX:SPL)
Australia flag Australia · Delayed Price · Currency is AUD
0.4100
-0.0400 (-8.89%)
Nov 10, 2026, 1:29 PM AEDT

Starpharma Holdings Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Starpharma Holdings stock has an average price target of $1.22. The average 1-year stock price forecast is 197.56% higher than the current stock price, while the lowest is $1.19 (+190.24%) and the highest is $1.25 (+204.88%).

Price Target: $1.22 (+197.56%)
Analyst Consensus: n/a

Price Target

Chart
TargetLowAverageMedianHigh
Price$1.19$1.22$1.22$1.25
Change+190.24%+197.56%+197.56%+204.88%

Analyst Ratings

According to 1 stock analyst, the rating for Starpharma Holdings is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingSep '25Jan '26Apr '26Aug '26Sep '26Oct '26
Strong Buy111111
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111111

Financial Forecast

Revenue This Year
6.30M
from 12.67M
Decreased by -50.27%
Revenue Next Year
26.25M
from 6.30M
Increased by 316.67%
EPS This Year
-0.03
from -0.02
EPS Next Year
0.00
from -0.03
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
5.16M4.34M9.76M5.85M12.67M6.30M
Revenue Growth
48.04%-15.87%124.64%-40.04%116.55%-50.27%
Operating Income
-16.15M-15.64M-8.17M-9.99M-7.47M-14.83M
Net Income
-16.15M-15.64M-8.17M-9.99M-7.47M-16.25M
EPS
-----0.02-0.03
Free Cash Flow
-----2.92M-1.10M
No. Analysts
-----1
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202720282029
High6.3M
Avg6.3M
Low6.3M

Revenue Growth

Revenue Growth202720282029
High
-50.3%
Avg
-50.3%
Low
-50.3%

EPS Forecast

EPS202720282029
High-0.03
Avg-0.03
Low-0.03

EPS Growth

EPS Growth202720282029
High-
Avg-
Low-